quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:00:59·42d
SECFiling
Seres Therapeutics Inc. logo

SEC Form 10-K filed by Seres Therapeutics Inc.

MCRB· Seres Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • MCRB
    Seres Therapeutics Inc.
    Health Care

Recent analyst ratings

  • May 8UpdateChardan Capital Markets$6.00
  • Oct 24UpdateJP Morgan-
  • Jun 26UpdateOppenheimer$12.00
  • Apr 21UpdateJP Morgan$7.00
  • Jul 23UpdateCanaccord Genuity$29.00
  • Jul 23UpdateChardan Capital$16.00

Related

  • PR3d
    Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
  • PR14d
    Seres Therapeutics to Present at CARB-X Investor Day
  • SEC38d
    SEC Form 8-K filed by Seres Therapeutics Inc.
  • SEC42d
    SEC Form 8-K filed by Seres Therapeutics Inc.
  • PR42d
    Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
  • INSIDER43d
    SEC Form 4 filed by Seres Therapeutics Inc.
  • INSIDER43d
    New insider Brady Kelly claimed ownership of 8,441 shares (SEC Form 3)
  • INSIDER48d
    SEC Form 4 filed by Officer Kender Richard N
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022